Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background And Objective: The aim of this study was to develop a nomogram for estimating the risk of postoperative major bleeding in patients who underwent surgery for percutaneous nephrolithotomy.

Methods: This retrospective study included 493 patients who had undergone unilateral percutaneous nephrolithotomy for kidney calculi at Third Xiangya Hospital from January 2022 to June 2024. Patients were temporally divided into a training set (the first 70% of treated patients) and a validation set (the last 30%). The least absolute shrinkage and selection operator, and multivariable logistic regression were employed to identify independent predictors of major bleeding upon which a nomogram was based.

Key Findings And Limitations: This study retrospectively analyzed 493 patients, of whom 86 suffered from major bleeding. Six independent risk factors were identified: solitary kidney, renal parenchymal thickness, surgical staging, surgical approach, tract size, and estimated glomerular filtration rate. The nomogram achieved an area under the curve of 0.81 (95% confidence interval [CI]: 0.76-0.87) in the training set and that of 0.84 (95% CI: 0.75-0.92) in the validation set. A decision curve analysis indicated that the nomogram is clinically valuable for predicting bleeding risk when the probability threshold is set between 0.04 and 0.89 in the training set. Limitations include the lack of external validation, which may affect the generalizability of the model.

Conclusions And Clinical Implications: The nomogram serves as an effective tool for predicting the risk of major bleeding after percutaneous nephrolithotomy and for aiding in preoperative assessments, helping surgeons identify high-risk patients for more informed decision-making.

Patient Summary: The study has identified the key factors that predict major bleeding following percutaneous nephrolithotomy, including the aspects of kidney condition and surgical techniques. This model can assist surgeons in identifying patients at a higher risk of bleeding and in enhancing surgical safety.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12314390PMC
http://dx.doi.org/10.1016/j.euros.2025.07.001DOI Listing

Publication Analysis

Top Keywords

major bleeding
24
percutaneous nephrolithotomy
16
bleeding percutaneous
12
training set
12
postoperative major
8
bleeding
8
retrospective study
8
493 patients
8
validation set
8
patients
7

Similar Publications

Objective: To demonstrate the effectiveness and safety of intraluminal endoscopic treatment of patients with adenomas of the major duodenal papilla and familial adenomatous polyposis.

Material And Methods: Over the past 4 years, 13 patients with adenomas of the major duodenal papilla and familial adenomatous polyposis underwent surgery in our hospital. Of these, 7 patients had exclusively extrapapillary adenomas without signs of spread to the ducts.

View Article and Find Full Text PDF

Background: Data on the levels of rivaroxaban-specific anti-factor Xa activity (AFXaA) within three weeks of starting high-dose rivaroxaban therapy in patients with cancer-associated thromboembolism (CAT) is limited. This study aimed to determine initial levels of rivaroxaban-specific AFXaA in patients with CAT to assist with drug monitoring.

Methods: This study included a total of 33 patients from December 2017 through January 2019.

View Article and Find Full Text PDF

Outcomes in Awake Laser Laryngeal Stenosis Surgery (ALLSS): A 5-Year Retrospective Review.

Laryngoscope

September 2025

UCSF Voice & Swallowing Center, Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA.

Objectives: In patients with significant upper airway stenosis, airway compromise can occur associated with general anesthesia (GA). A previous study demonstrated the feasibility of awake laser laryngeal stenosis surgery (ALLSS) in the operating room (OR) in five patients. This study sought to determine patient outcomes of ALLSS.

View Article and Find Full Text PDF

Background: Current guidelines recommend clopidogrel in patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI), yet the comparative benefits are unclear.

Aims: The aim of this study was to evaluate the efficacy and safety of ticagrelor versus clopidogrel in patients with CCS undergoing PCI.

Methods: We searched PubMed/MEDLINE, EMBASE, CENTRAL databases from inception to February 15, 2025.

View Article and Find Full Text PDF

Introduction: Venous thromboembolism (VTE) is a leading cause of mortality in cancer patients, and a substantial number of patients are being treated with oral anticoagulants. We aim to assess the comparative effectiveness of direct oral anticoagulants (DOACs) compared to warfarin for VTE treatment in cancer patients.

Methods: In this retrospective cohort study, we included 2,367 cancer patients who are new users of oral anticoagulants (OACs) for VTE treatment from 2009 to 2021 in NHS Scotland.

View Article and Find Full Text PDF